Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 20: 317-319, 1974;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bondar, R. J. L.
Right arrow Articles by Moss, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bondar, R. J. L.
Right arrow Articles by Moss, G. A.

Clinical Chemistry, Vol 20, 317-319, Copyright © 1974 by the American Association for Clinical Chemistry

Enhancing Effect of Glutamate on Apparent Serum ggr-Glutamyltranspeptidase Activity

Richard J. L. Bondar 1 and Gerald A. Moss 1

1 Research and Development Division, Worthington Biochemical Corp., Freehold, N. J. 07728.

Free glutamate increases the apparent serum ggr-glutamyltranspeptidase (ggr-GTP) activity in the normal range by 100%, and in the 10-fold normal range by 20%. This increase is greatest, and is the same, at two very different concentrations, 60 and 1000 µmol of glutamate per liter of the final reaction mixture. Glutamate concentrations greater than 10 mmol/liter inhibit serum ggr-GTP. Elevated serum glutamate concentrations or glutamate released by substrate breakdown will therefore give false and possibly variable results. To minimize variations in activity, the assay should be run in the presence of 1.0 mmol of glutamate per liter. This concentration, which is 100 times greater than that which normal serum would contribute (with respect to free glutamate) to the assay system, thus masks any effect of extraneous glutamate.


Key Words: diagnostic aid • liver disease • spectrophotometry

Submitted on July 9, 1973
Accepted on November 12, 1973






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American Association for Clinical Chemistry.